Discoveries made possible by DNA
Nearly 70 years ago, James Watson and Francis Crick proposed the double-helix model of DNA, transforming how scientists understood heredity and launching the field of molecular biology. On November 6, Watson died in New York at age 97. Although a controversial figure, contributed to defining DNA structure and helped characterize the molecule that remains fundamental to understanding biology.

Now, genes and DNA are now closely linked in concept, but scientists in Watson and Crick’s era did not understand the chemical basis of inheritance. Watson and Crick suspected a molecule called DNA — which was first identified in the 1860s — could hold the answer. Earlier findings by Phoebus Levene and Erwin Chargaff revealed the basic chemical components of DNA and how they were arranged. Building on this work and drawing on crucial X-ray crystallography data from Maurice Wilkins and Rosalind Franklin some of which was shared without her consent, Watson and Crick built a physical model that revealed DNA’s double-helix structure. Although refinements have been made since their original published paper, the core model has endured. Watson, Crick and Wilkins were awarded the 1962 Nobel Prize in Physiology or Medicine for their work.
The discovery of the double helix answered key questions about how genetic information is encoded and faithfully copied. Its complementary strand structure explained how DNA can replicate with high fidelity, as each strand serves as a template for creating a new partner. The DNA sequence also hinted at how genes direct protein synthesis, although the full genetic code was not deciphered until more than a decade later. The breakthrough transformed the understanding of life at the molecular level and helped launch the field of molecular biology.
The double-helix model triggered a cascade of scientific breakthroughs, including the development of recombinant DNA technology. Advances in DNA sequencing have enabled scientists to map genes in detail, trace evolutionary relationships and uncover the molecular foundations of many diseases. These efforts culminated in the Human Genome Project, a landmark achievement that produced the first complete map of human genes.
DNA now sits at the center of modern science and medicine, powering technologies that allow more precise diagnostics and increasingly personalized medical care. New frontiers have emerged — gene editing is possible thanks to tools such as CRISPR–Cas9 and synthetic biology, which combines engineering and genetics, is being used to create new biological systems or redesign existing ones. Beyond healthcare, DNA-based tools support public-health surveillance, the development of more resilient crops and the monitoring of the genetic health of endangered species. These advances are built on the ability to read, interpret and rewrite DNA’s underlying code.
Although the double-helix model answered fundamental questions, many mysteries remain, from the roles of noncoding DNA to the complex layers of epigenetic modification and genome-wide regulatory networks. New tools and technology continue to expand what questions can be answered, ensuring that DNA research will fuel scientific innovation and inspire the next era of discovery.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

Building the blueprint to block HIV
Wesley Sundquist will present his work on the HIV capsid and revolutionary drug, Lenacapavir, at the ASBMB Annual Meeting, March 7–10, in Maryland.

Gut microbes hijack cancer pathway in high-fat diets
Researchers at the Feinstein Institutes for Medical Research found that a high-fat diet increases ammonia-producing bacteria in the gut microbiome of mice, which in turn disrupts TGF-β signaling and promotes colorectal cancer.

Mapping fentanyl’s cellular footprint
Using a new imaging method, researchers at State University of New York at Buffalo traced fentanyl’s effects inside brain immune cells, revealing how the drug alters lipid droplets, pointing to new paths for addiction diagnostics.

Designing life’s building blocks with AI
Tanja Kortemme, a professor at the University of California, San Francisco, will discuss her research using computational biology to engineer proteins at the 2026 ASBMB Annual Meeting.

Cholesterol as a novel biomarker for Fragile X syndrome
Researchers in Quebec identified lower levels of a brain cholesterol metabolite, 24-hydroxycholesterol, in patients with fragile X syndrome, a finding that could provide a simple blood-based biomarker for understanding and managing the condition.

How lipid metabolism shapes sperm development
Researchers at Hokkaido University identify the enzyme behind a key lipid in sperm development. The findings reveal how seminolipids shape sperm formation and may inform future diagnostics and treatments for male infertility.